BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10079690)

  • 1. [EEG pattern indicative of dialysis encephalopathy].
    Dobato JL; Caminero AB
    Neurologia; 1999 Jan; 14(1):35. PubMed ID: 10079690
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
    Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
    Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dialysis encephalopathy in chronic renal failure].
    Markiewicz K; Bubiński R
    Pol Tyg Lek; 1980 Jul; 35(30):1159-62. PubMed ID: 7001402
    [No Abstract]   [Full Text] [Related]  

  • 4. [Encephalopathy in chronic haemodialyzation and its possible connection with hypercalcaemia].
    Sotorník I; Honzák R; Vanĕcek V; Povýsil C; Dráb K; Mrhová O; Stĕpánová I
    Cas Lek Cesk; 1982 Jun; 121(24):751-5. PubMed ID: 7116377
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aluminum and magnesium burden of dialysis patients using antacids. A comparative study].
    Eichhorn M
    Fortschr Med; 1989 Aug; 107(23):502-6. PubMed ID: 2670719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uremic encephalopathy, dialysis encephalopathy].
    Kinugasa E
    Nihon Rinsho; 2004 Jan; 62 Suppl():424-8. PubMed ID: 15011399
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current concepts of the role of aluminum in chronic kidney failure patients].
    Gruev I; Belovezhdov N
    Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperaluminemia in renal failure: the influence of age and citrate intake.
    Bakir AA; Hryhorczuk DO; Ahmed S; Hessl SM; Levy PS; Spengler R; Dunea G
    Clin Nephrol; 1989 Jan; 31(1):40-4. PubMed ID: 2914409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudo-porphyria cutanea tarda in patients with chronic renal insufficiency and in patients with renal transplants].
    Antonello A; Peserico A; Corsano A; Zannini G; Fagiolo U
    Minerva Chir; 1980 May; 35(10):775-7. PubMed ID: 7005735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Causes of hyperaluminemia in patients maintained on hemodialysis].
    Balezina OA; Ermolenko VM; Bel'skii NK; Nebol'sina LA; Segel'man VS
    Ter Arkh; 1982; 54(7):85-6. PubMed ID: 7135231
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of dialysis encephalopathy with deferoxamine].
    Starkstein S; Berthier M; Nogués M; Leiguarda R
    Medicina (B Aires); 1986; 46(3):327-31. PubMed ID: 3574092
    [No Abstract]   [Full Text] [Related]  

  • 12. Dialysis disequilibrium syndrome: a narrative review.
    Patel N; Dalal P; Panesar M
    Semin Dial; 2008; 21(5):493-8. PubMed ID: 18764799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal transplant to patients with latent or manifest dialysis dementia].
    Ricart MJ; Caralps A; Brulles A; Andreu J; Sola R; Oppenheimer F; Vilardell J
    Rev Clin Esp; 1982 Apr; 165(2):109-12. PubMed ID: 6750708
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and pathophysiological aspects of neurological complications in renal failure.
    De Deyn PP; Saxena VK; Abts H; Borggreve F; D'Hooge R; Marescau B; Crols R
    Acta Neurol Belg; 1992; 92(4):191-206. PubMed ID: 1332359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
    Válek A; Sulková S; Laurinová Z
    Ter Arkh; 1991; 63(6):89-93. PubMed ID: 1948757
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dialysis encephalopathy, dialysis dementia].
    Kinugasa E; Ideura T; Akizawa T
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):139-42. PubMed ID: 11031916
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP; Heaf JG
    Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract]   [Full Text] [Related]  

  • 18. Uremic encephalopathies: clinical, biochemical, and experimental features.
    Mahoney CA; Arieff AI
    Am J Kidney Dis; 1982 Nov; 2(3):324-36. PubMed ID: 6756130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fatal interplay of aluminum and citrate in chronic renal failure: a lesson from three decades ago.
    Bakir AA
    Artif Organs; 2015 Feb; 39(2):87-9. PubMed ID: 25683287
    [No Abstract]   [Full Text] [Related]  

  • 20. [The natural history of dialysis encephalopathy (author's transl)].
    Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
    Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.